FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2023
Back to search
Official data from USPTO
CARMINE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARMINE THERAPEUTICS
ST13
US500000079292145Class
5, 42
Filing
79292145
Registration
6841265
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
01/03/2023
Trademark type
Word
Nice classes
5, 42
Filing date
07/01/2020
Registration date
09/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2022
Last transaction
09/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
SG
Examiner
CIANCI, RYAN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Carmine Therapeutics Pte. Ltd.
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparationsred blood cells comprising of extracellular vesicles for therapeutic medical applications; biological preparationsred blood cells comprising of extracellular vesicles containing nucleic acids for medical gene therapy
Class 42
Scientific and medical research; biopharmaceutical research and development of new pharmaceutical medicines based on gene therapy; pharmaceutical research and development of new pharmaceutical medicines based on gene therapy; product development for others in the field of biotechnology
Publications
History of USPTO decisions and trademark events.
41 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/14/2022
FIMP
FINAL DISPOSITION PROCESSED
12/13/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/13/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2022
ALIE
ASSIGNED TO LIE
05/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/09/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/13/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/26/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/26/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
12/03/2021
CNSL
SUSPENSION LETTER WRITTEN
12/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/02/2021
GNFR
FINAL REFUSAL E-MAILED
06/02/2021
CNFR
FINAL REFUSAL WRITTEN
06/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2021
RFNT
REFUSAL PROCESSED BY IB
11/21/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/05/2020
RFRR
REFUSAL PROCESSED BY MPU
11/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/15/2020
CNRT
NON-FINAL ACTION WRITTEN
10/14/2020
DOCK
ASSIGNED TO EXAMINER
10/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/20/2020
Continuous trademark protection
Get notified about every new filing that threatens CARMINE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.